Amneal and Macleods Issued Voluntary Drug Recalls
The FDA has classified recalls for diabetes and antipsychotic medications due to manufacturing defects and purity concerns.
Updated on Sept. 30, 2026 in Diabetes
Live Poll
Do you trust that pharmaceutical manufacturers are maintaining high enough standards for your medications?
Amneal Pharmaceuticals and Macleods Pharma have issued voluntary recalls for specific batches of exenatide and olanzapine across the United States. The FDA has categorized these actions based on the potential health risks associated with each product defect.
Why it matters
These recalls highlight ongoing efforts to maintain manufacturing standards for medications used to manage chronic conditions like diabetes and mental health. Patients rely on consistent drug potency and delivery mechanisms, and these recalls address significant failures in meeting regulatory specifications.
The recalls involve 5,694 prefilled exenatide pens and 22,032 bottles of olanzapine following failure to meet manufacturing and degradation specifications. The FDA designated the Amneal exenatide recall as a Class II action and the Macleods olanzapine recall as a Class III action.
The players
Amneal Pharmaceuticals
A pharmaceutical company that produces a range of medications including the recalled exenatide pens.
Macleods Pharma
A pharmaceutical manufacturer based in Mumbai, India, known for producing various therapeutic drugs.
FDA
The federal agency responsible for overseeing drug safety and classifying market recalls in the United States.
The details
The exenatide recall was triggered by a delivery system defect that can result in empty prefilled pens, potentially interrupting treatment for diabetes. Separately, the olanzapine recall occurred because the medication failed to meet established impurities and degradation standards, which could affect the safety or effectiveness of the antipsychotic treatment.
Timeline
September 30, 2026: The drug recalls were reported.
Health Landscape
These recalls reflect the standard FDA enforcement protocols for maintaining strict quality control in the global pharmaceutical supply chain. The classifications provide a tiered response to manufacturing deviations that occur even in established clinical drug programs.
If you are currently taking exenatide or olanzapine, check your prescription packaging and consult your pharmacist to verify if your batch is affected by these recalls. Discuss any concerns about potential treatment interruptions or alternative medication options with your primary care physician.
The takeaway
Manufacturing safety relies on rigorous oversight to ensure that drug delivery systems and chemical purity standards are maintained. If you suspect your medication is part of a recall, store it safely out of reach and contact your pharmacist immediately for verification and guidance on next steps.
Further reading
For more information on managing conditions during product supply changes, visit Diabetes.
Source note: This article includes information reported by ETPharma.
Live Poll
Do you trust that pharmaceutical manufacturers are maintaining high enough standards for your medications?
